Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Entasis Therapeutics Holdings Inc
(NQ:
ETTX
)
N/A
UNCHANGED
Last Price
Updated: 3:59 PM EDT, Jul 8, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Entasis Therapeutics Holdings Inc
< Previous
1
2
Next >
Over $42 Million Bet On This Biotechnology Stock? 4 Penny Stocks Insiders are Buying
July 14, 2022
US producer prices likely to rise 0.8% on the month in June to match the previous month’s growth. Investors, meanwhile, focused on some notable insider trades.
Via
Benzinga
58 Biggest Movers From Yesterday
May 24, 2022
Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.
Via
Benzinga
Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share
May 23, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022
May 06, 2022
Upgrades For Coupang Inc (NYSE:CPNG), JP Morgan upgraded the previous rating of Neutral to Overweight. The stock has a 52-week-high of $46.00 and a 52-week-low of $11.91. At the end of the last trading...
Via
Benzinga
Entasis Therapeutics Hldg: Q1 Earnings Insights
April 27, 2022
Entasis Therapeutics Hldg (NASDAQ:ETTX) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 26, 2022
Via
Benzinga
Wednesday Top Stock News: 8 Analyst Upgrades and Downgrades Today
March 16, 2022
We're taking a look at the top stock news for Wednesday and that includes the latest analysts upgrades and downgrades you need to know about!
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022
March 16, 2022
Upgrades Bernstein upgraded the previous rating for Stryker Corp (NYSE:SYK) from Market Perform to Outperform. For the fourth quarter, Stryker had an EPS of $2.71, compared to...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2022
March 08, 2022
Upgrades According to Janney Montgomery Scott, the prior rating for Wintrust Financial Corp (NASDAQ:WTFC) was changed from Neutral to Buy. Wintrust Finl earned $1.58 in the fourth...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 4, 2022
March 04, 2022
Upgrades According to Susquehanna, the prior rating for Knight-Swift Transportation Holdings Inc (NYSE:KNX) was changed from Neutral to Positive. Knight-Swift earned $1.61 in the...
Via
Benzinga
Recap: Entasis Therapeutics Q4 Earnings
March 03, 2022
Entasis Therapeutics Hldg (NASDAQ:ETTX) reported its Q4 earnings results on Thursday, March 3, 2022 at 07:30 AM. Here's what investors need to know about the...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
February 02, 2022
Gainers Epizyme (NASDAQ:EPZM) stock increased by 14.2% to $1.41 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of 9.6...
Via
Benzinga
54 Biggest Movers From Yesterday
February 03, 2022
Gainers MDJM Ltd (NASDAQ: MDJH) shares surged 35.6% to close at $2.44 on Wednesday after gaining 10% on Tuesday. GWG Holdings, Inc. (NASDAQ: GWGH) gained 31.6% to settle at $4.50...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 02, 2022
Gainers Pharming (NASDAQ:PHAR) shares increased by 15.8% to $10.21 during Wednesday's pre-market session. The company's market cap stands at $652.2 million....
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
February 02, 2022
Good morning, investor! We're beginning another busy day of trading with a look at the biggest pre-market stock movers for Wednesday!
Via
InvestorPlace
30 Stocks Moving in Friday's Pre-Market Session
October 29, 2021
Gainers DBV Technologies S.A. (NASDAQ: DBVT) rose 20.3% to $3.68 in pre-market trading after declining 15% on Thursday. DBV Technologies, disclosed that on Oct. 14, it received...
Via
Benzinga
Week In Review: China's Hansoh Signs Two siRNA Deals Worth $1.7 Billion
October 23, 2021
Hansoh announced a $1.3 billion deal to develop three siRNA candidates from London's Silence Therapeutics. In the past week, Hansoh also revealed a $456 million deal with Korea's OliX Pharma for China...
Via
Talk Markets
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 22, 2021
Gainers Nutriband (NASDAQ:NTRB) shares rose 15.52% to $6.72 during Friday's pre-market session. The market value of their outstanding shares is at $49.8 million. T2...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 20, 2021
Gainers F-star Therapeutics (NASDAQ:FSTX) shares increased by 18.74% to $7.6 during Wednesday's pre-market session. The market value of their outstanding shares is at...
Via
Benzinga
16 Stocks Moving in Wednesday's Pre-Market Session
October 20, 2021
Gainers Troika Media Group, Inc. (NASDAQ: TRKA) rose 27.3% to $2.05 in pre-market trading after surging around 9% on Tuesday. The company, last month, said it swung to a loss in...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 19, 2021
Gainers Sesen Bio (NASDAQ:SESN) stock mo...
Via
Benzinga
The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio
October 19, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Entasis Announces Positive Data For Late-Stage Study Of SUL-DUR In...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 19, 2021
Gainers Entasis Therapeutics Hldg (NASDAQ:ETTX) shares moved upwards by 16.72% to $3.63 during Tuesday's pre-market session. The company's market cap stands at $...
Via
Benzinga
Entasis Shares Rally On Positive Data From Drug-Resistant Bacterial Infection Candidate
October 19, 2021
Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) announced topline results from its Phase 3 ATTACK trial of sulbactam-durlobactam (SUL-DUR) versus colistin in...
Via
Benzinga
18 Stocks Moving in Tuesday's Pre-Market Session
October 19, 2021
Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 26.1% to $2.03 in pre-market trading after surging 18% on Monday. Kaival Brands Innovations recently announced...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
September 27, 2021
Gainers Paratek Pharmaceuticals (NASDAQ:PRTK...
Via
Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Cerevel Therapeutics...
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Friday's Intraday Session
September 17, 2021
Gainers Corvus Pharmaceuticals (NASDAQ:CRVS
Via
Benzinga
Why Are Entasis Therapeutics Shares Moving Higher On Thursday?
September 16, 2021
Entasis Therapeutics Holdings Inc (NASDAQ: ETTX) stock is up sharply after the journal Nature published an article on the potential of its preclinical candidate...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 16, 2021
Gainers Leap Therapeutics (NASDAQ:LPTX) stock moved upwards by 27.72% to $2.46 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume...
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.